Big pharma accused of ‘free-riding on nature’ as global fund attracts just $7,000

The Cali Fund, a global biodiversity fund, has attracted a mere $7,000 in donations from big pharmaceutical companies, falling far short of its $1 billion annual target. This lack of contribution has led to accusations that these companies are "free-riding on nature", meaning they are profiting from the genetic resources of the natural world without giving back. The significance of this lies in the fact that these companies are among the biggest beneficiaries of biodiversity, and their failure to contribute to conservation efforts could have severe consequences for the environment.

Why it matters

The Cali Fund aims to raise money for biodiversity from drug companies, but it has only attracted a small amount of money. This could lead to increased scrutiny of big pharma's environmental impact.

Market impact

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to The Guardian. For information only — not financial advice.